compound introduction
IDO-IN-8 (NLG-1487) is an indoleamine 2,3-dioxygenase ( IDO ) inhibitor extracted from patent WO WO2012142237A1, compound 1487, has an IC 50 of 1-10 μM. In Vitro IDO-IN-8 (Compound 1487) is an indoleamine 2,3-dioxygenase (IDO) inhibitor with an IC 50 of 1-10 μM (this is the concentration of IDO-IN-8 at which inhibits 50% of enzymatic activity using recombinant human IDO). MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:IDO 1-10 μM (IC 50 )
